<DOC>
	<DOC>NCT03016364</DOC>
	<brief_summary>The purpose of this trial is to determine whether Application (APP) would help clinical doctors to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets in advanced patients with cancer pain.</brief_summary>
	<brief_title>Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain</brief_title>
	<detailed_description />
	<mesh_term>Oxycodone</mesh_term>
	<criteria>a histologically confirmed diagnosis of Cancer or Sarcoma advanced patients with severe cancer pain(score &gt;3) having used or expected to use the Oxycodone Hydrochloride Prolongedrelease Tablets allergic to Oxycodone Hydrochloride Prolongedrelease Tablets, or other reasons (determined by clinical doctors) unable to use the Opioids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>